(Total Views: 273)
Posted On: 08/31/2022 2:25:53 PM
Post# of 17

$MDGL News Article - Madrigal Pharmaceuticals Initiates the MAESTRO-NASH Outcomes Study Evaluating Resmetirom for the Treatment of Patients with Compensated NASH Cirrhosis https://marketwirenews.com/news-releases/madr...17944.html


My Twitter: WhyteStocks